A Study Evaluating BAT3306 Compared With Keytruda® in NSCLC Cancer Participants — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study Evaluating BAT3306 Compared With Keytruda® in NSCLC Cancer Participants — Stella

Recruiting

Back to Carcinoma, Non-Small-Cell Lung trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

China

Union Hospital Tongji Medical College Huazhong University of Science & Technology, Wuhan, Hubei

Key details

Phase

Early testing

Sponsor

Bio-Thera Solutions

Enrollment target

~140 participants

Started

October 2025

Primary completion

February 2027

Age range

18 Years – 75 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov